Wenjun He

2.1k citations
77 papers · 1.1k indexed · h-index 20
Topics
Tissue Engineering and Regenerative Medicine (7 papers)Pluripotent Stem Cells Research (7 papers)Pulmonary Hypertension Research and Treatments (7 papers)
Journals
Journal of Clinical InvestigationSHILAP Revista de lepidopterologíaPLoS ONE

In The Last Decade

Wenjun He

69 papers receiving 1.1k citations

Peers

Wenjun He
Comparison fields: 5 of 129
  • Molecular Biology 425
  • Surgery 247
  • Biomaterials 206
  • Oncology 188
  • Immunology 130
Replace Long Xiao with:
Long Xiao China
Jun Young Kim South Korea
Jieun Jung South Korea
Hiromitsu Watanabe Japan
Di Zhang China
Katarzyna Komosińska‐Vassev Poland
Jun Zhu China
Yuheng Zhang China
Yang Xiao China
Wenjun He relative to Long Xiao China Long Xiao's profile →
Citations per field
00.5×2.5×
Long Xiao · 1×
Citations per year

Countries citing papers authored by Wenjun He

Since Specialization
Citations

This map shows the geographic impact of Wenjun He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjun He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjun He more than expected).

Fields of papers citing papers by Wenjun He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjun He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjun He. The network helps show where Wenjun He may publish in the future.

Co-authorship network of co-authors of Wenjun He

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjun He. A scholar is included among the top collaborators of Wenjun He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjun He. Wenjun He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 2
4 0
5 4
6 8
7 3
8 10
9 54
10 5
11 23
12 1
13 5
14 30
15
[Progress in the study of some important natural bioactive cyclopeptides].
4
16 2
17 9
18
[Research progress on pharmacological activities of echinacoside].
19
19 21
20 163

About Wenjun He

Wenjun He is a scholar working on Rehabilitation, Hepatology and Biochemistry, having authored 77 papers that have together received 1.1k indexed citations. Recurring topics across this work include Tissue Engineering and Regenerative Medicine (7 papers), Pluripotent Stem Cells Research (7 papers) and Pulmonary Hypertension Research and Treatments (7 papers). The work is most often cited by research in Biomaterials (206 citations), Drug Discovery (2 citations) and Rehabilitation (53 citations). Wenjun He has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Shilin Yang, Xiaoran Li, Qiongming Xu, Changyong Wang, Yanli Liu, Shuanghong Lü, Tong Hao, Cuimi Duan, Dexue Li and Qiang Fu. Their work appears in journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026